- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT03996707
Immediate Weight-bearing Verses Non-Weight-bearing After Foot & Ankle Surgery
Immediate Weight-bearing Verses Non-Weight-bearing After Foot & Ankle Surgery: A Prospective Analysis
Обзор исследования
Статус
Вмешательство/лечение
Подробное описание
The study is a randomized 1:1, controlled trial, prospective in nature, where participants undergoing foot and ankle surgery will be randomly placed into one of two groups; an immediate weight-bearing group or a non-weight-bearing group. The patients will be randomly placed into the study group and control group if they meet all eligibility criteria.
This study will be conducted at 5 investigative clinic sites; West Penn Hospital, Forbes Regional Hospital, Jefferson Regional Hospital, Bethel Park Surgery Center, and Monroeville Surgery. Recruitment will stop when a minimum of 230 subjects are consented.
The study duration will require 7 visits to the clinic plus a surgery day therefore will require a pre-surgical visit/screening, surgery procedural day and six outpatient post-operative visits to the clinics. The entire follow up period will occur over 2 years.
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
Pennsylvania
-
Clairton, Pennsylvania, Соединенные Штаты, 15025
- Steel Valley Orthopaedic and Sports Medicine
-
Pittsburgh, Pennsylvania, Соединенные Штаты, 15224
- The Foot & Ankle Institute/Western Pennsylvania Hospital
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Males or females age 18 to 89 years
- Undergoing foot and ankle surgery
- Must be able to read and understand English and consent for themselves
Exclusion Criteria:
- Diagnosed peripheral neuropathy
- Diagnosed peripheral vascular disease
- Documented infection to the surgical extremity
- Previous surgery to the surgical limb
- Laboratory abnormalities that indicate clinically significant hematologic, hepatobiliary, or renal disease which would predispose patients to poor healing and/or non-union
- Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Другой: Immediate protected weight-bearing
|
Immediate protected weight bearing in a CAM walking boot following foot & ankle surgery
Другие имена:
|
|
Другой: Traditional non weight bearing
Strict non-weight-bearing
|
Strict non weight bearing for 6 weeks following foot & ankle surgery
Другие имена:
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Временное ограничение: Both Arms: Screening
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Screening
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Временное ограничение: Both Arms: Post-operative 6-8 weeks
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 6-8 weeks
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Временное ограничение: Both Arms: Post-operative 3 month
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 3 month
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Временное ограничение: Both Arms: Post-operative 12 month
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 12 month
|
|
Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale
Временное ограничение: Both Arms: Post-operative 24 month
|
American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot.
Pain, Function, Alignment Score 0-100, 100 being most healthy
|
Both Arms: Post-operative 24 month
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Временное ограничение: Both Arms: Screening
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Screening
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Временное ограничение: Both Arms: Post-operative 6-8 weeks
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 6-8 weeks
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Временное ограничение: Both Arms: Post-operative 3 month
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 3 month
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Временное ограничение: Both Arms: Post-operative 12 month
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 12 month
|
|
Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND
Временное ограничение: Both Arms: Post-operative 24 month
|
36 Item Short Form Survey (SF36) RAND.
8 scaled scores, 0-100, 100 being most healthy
|
Both Arms: Post-operative 24 month
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Screening
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Screening
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 2-3 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 2-3 weeks
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 6-8 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 6-8 weeks
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 3 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 3 month
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 6 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 6 month
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 12 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 12 month
|
|
Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 24 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation.
|
Both arms: Post-operative 24 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Screening
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Screening
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 2-3 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 2-3 weeks
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 6-8 weeks
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 6-8 weeks
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 3 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 3 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 6 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 6 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 12 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 12 month
|
|
Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods
Временное ограничение: Both arms: Post-operative 24 month
|
Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures.
|
Both arms: Post-operative 24 month
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Ryan L. McMillen, DPM, FACFAS, Steel Valley Orthopaedic & Sports Medicine
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Другие идентификационные номера исследования
- 2019-124JH
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .
Клинические исследования Weight Bearing
-
Damascus UniversityЗавершенныйЗаболевания суставов | Осложнения эндопротезирования | Артрит КоленоСирийская Арабская Республика
-
University of RochesterЗавершенныйОжирение | Избыточный весСоединенные Штаты
-
University of North Carolina, Chapel HillWeight Watchers InternationalЗавершенныйИзбыточный вес и ожирениеСоединенные Штаты
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Health services; Alberta Innovates...Завершенный
-
The Miriam HospitalUniversity of Tennessee; Weight Watchers InternationalЗавершенный
-
University of PennsylvaniaWW International IncЗавершенныйИзбыточный вес и ожирениеСоединенные Штаты
-
Medical University of South CarolinaWeight Watchers InternationalЗавершенныйОжирение | Избыточный вес | Диабет 2 типаСоединенные Штаты
-
DePuy InternationalПрекращеноОстеоартрит, КоленоСоединенное Королевство
-
The Miriam HospitalUniversity of Tennessee; Weight Watchers InternationalЗавершенный
-
Medacta USAОтозван